David A. Saperstein

4.0k total citations · 1 hit paper
36 papers, 2.8k citations indexed

About

David A. Saperstein is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, David A. Saperstein has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Ophthalmology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in David A. Saperstein's work include Retinal Development and Disorders (19 papers), Retinal Diseases and Treatments (16 papers) and Photoreceptor and optogenetics research (9 papers). David A. Saperstein is often cited by papers focused on Retinal Development and Disorders (19 papers), Retinal Diseases and Treatments (16 papers) and Photoreceptor and optogenetics research (9 papers). David A. Saperstein collaborates with scholars based in United States, Switzerland and Poland. David A. Saperstein's co-authors include Krzysztof Palczewski, Sławomir Filipek, Yan Liang, Andreas Engel, Dimitrios Fotiadis, Akiko Maeda, Yoshikazu Imanishi, Tadao Maeda, Eric R. Holz and Peter A. Campochiaro and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

David A. Saperstein

36 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rhodopsin dimers in native disc membranes

2003 588 citations Dimitrios Fotiadis, Yan Liang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Saperstein United States	20	2.4k	1.3k	726	343	194	36	2.8k
J. Hugh McDowell United States	33	3.3k 1.4×	2.4k 1.8×	455 0.6×	157 0.5×	234 1.2×	66	3.8k
Michael Rosconi United States	8	1.1k 0.5×	692 0.5×	587 0.8×	548 1.6×	58 0.3×	15	2.0k
Elena V. Olshevskaya United States	29	2.6k 1.1×	1.8k 1.3×	861 1.2×	111 0.3×	106 0.5×	47	2.9k
Ronald A. Bush United States	42	4.7k 2.0×	2.0k 1.5×	1.8k 2.5×	893 2.6×	545 2.8×	76	5.4k
Mark P. Krebs United States	32	2.0k 0.8×	1.1k 0.8×	225 0.3×	96 0.3×	403 2.1×	73	2.6k
Laurie L. Molday Canada	38	4.2k 1.7×	1.6k 1.2×	1.3k 1.8×	607 1.8×	448 2.3×	71	4.8k
Peter D. Calvert United States	20	1.9k 0.8×	1.3k 1.0×	303 0.4×	48 0.1×	272 1.4×	35	2.2k
Muayyad R. Al‐Ubaidi United States	31	2.8k 1.2×	998 0.8×	823 1.1×	208 0.6×	334 1.7×	92	3.3k
François Paquet‐Durand Germany	33	2.8k 1.2×	997 0.8×	1.3k 1.8×	270 0.8×	141 0.7×	109	3.3k
Igor V. Peshenko United States	29	2.0k 0.8×	923 0.7×	801 1.1×	107 0.3×	89 0.5×	63	2.1k

Countries citing papers authored by David A. Saperstein

Since Specialization

Citations

This map shows the geographic impact of David A. Saperstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Saperstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Saperstein more than expected).

Fields of papers citing papers by David A. Saperstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Saperstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Saperstein. The network helps show where David A. Saperstein may publish in the future.

Co-authorship network of co-authors of David A. Saperstein

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Saperstein. A scholar is included among the top collaborators of David A. Saperstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Saperstein. David A. Saperstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruiz‐Moreno, José M., Carol L. Shields, David A. Saperstein, et al.. (2025). Phenotypic Spectrum of Benign Lobular Inner Nuclear Layer Proliferations. Ophthalmology Retina. 9(10). 1017–1022. 1 indexed citations

Dinculescu, Astra, Brian A. Link, & David A. Saperstein. (2021). Retinal Gene Therapy for Usher Syndrome: Current Developments, Challenges, and Perspectives. International Ophthalmology Clinics. 61(4). 109–124. 8 indexed citations

Geng, Ruishuang, Omar Akil, Ruben Stepanyan, et al.. (2017). Modeling and Preventing Progressive Hearing Loss in Usher Syndrome III. Scientific Reports. 7(1). 68 indexed citations

Koenekoop, Robert K., Ruifang Sui, Juliana Maria Ferraz Sallum, et al.. (2014). Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial. The Lancet. 384(9953). 1513–1520. 77 indexed citations

Koenekoop, Robert K., Julie Racine, Ruifang Sui, et al.. (2011). Oral synthetic cis-retinoid therapy in subjects with Leber congenital amaurosis (LCA) due to lecithin:retinol acyltransferase (LRAT) or retinal pigment epithelial 65 protein (RPE65) mutations: preliminary results of a phase Ib open label trial. European Journal of Ophthalmology. 1 indexed citations

Singh, Christopher N. & David A. Saperstein. (2008). COMBINATION TREATMENT WITH REDUCED-FLUENCE PHOTODYNAMIC THERAPY AND INTRAVITREAL INJECTION OF TRIAMCINOLONE FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN MACULAR DEGENERATION. Retina. 28(6). 789–793. 18 indexed citations

Sun, Wenyu, Christina Gerth‐Kahlert, Akiko Maeda, et al.. (2007). Novel RDH12 mutations associated with Leber congenital amaurosis and cone-rod dystrophy: Biochemical and clinical evaluations. Vision Research. 47(15). 2055–2066. 41 indexed citations

Saperstein, David A., et al.. (2007). SURGICAL EVACUATION OF SUBMACULAR EXUDATES SECONDARY TO A VASOPROLIFERATIVE TUMOR OF THE RETINA. Retinal Cases & Brief Reports. 1(4). 244–245. 1 indexed citations

Campochiaro, Peter A., Quan Dong Nguyen, Syed Mahmood Shah, et al.. (2006). Adenoviral Vector-Delivered Pigment Epithelium-Derived Factor for Neovascular Age-Related Macular Degeneration: Results of a Phase I Clinical Trial. Human Gene Therapy. 17(2). 167–176. 263 indexed citations

10.

Filipek, Sławomir, Krystiana A. Krzyśko, Dimitrios Fotiadis, et al.. (2004). A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface. Photochemical & Photobiological Sciences. 3(6). 628–638. 134 indexed citations

11.

Liang, Yan, Dimitrios Fotiadis, Tadao Maeda, et al.. (2004). Rhodopsin Signaling and Organization in Heterozygote Rhodopsin Knockout Mice. Journal of Biological Chemistry. 279(46). 48189–48196. 135 indexed citations

12.

Fotiadis, Dimitrios, Yan Liang, Sławomir Filipek, et al.. (2004). The G protein‐coupled receptor rhodopsin in the native membrane. FEBS Letters. 564(3). 281–288. 182 indexed citations

13.

Rosenfeld, Philip J., David A. Saperstein, Neil M. Bressler, et al.. (2004). Photodynamic therapy with verteporfin in ocular histoplasmosis: Uncontrolled, open-label 2-year study. Ophthalmology. 111(9). 1725–1733. 32 indexed citations

14.

Kim, Jee-Hee, et al.. (2003). Subluxation of transscleral sutured posterior chamber intraocular lens (TSIOL). American Journal of Ophthalmology. 136(2). 382–384. 23 indexed citations

15.

Fotiadis, Dimitrios, Yan Liang, Sławomir Filipek, et al.. (2003). Rhodopsin dimers in native disc membranes. Nature. 421(6919). 127–128. 588 indexed citations breakdown →

16.

Imanishi, Yoshikazu, Ning Li, Izabela Sokal, et al.. (2002). Characterization of retinal guanylate cyclase‐activating protein 3 (GCAP3) from zebrafish to man. European Journal of Neuroscience. 15(1). 63–78. 91 indexed citations

17.

Sohocki, Melanie M., Stephen P. Daiger, Sara J. Bowne, et al.. (2000). Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Human Mutation. 17(1). 42–51. 265 indexed citations

18.

Small, Kent W., Nitin Udar, Robert R. Klein, et al.. (1999). North Carolina macular dystrophy (MCDR1) locus: a fine resolution genetic map and haplotype analysis.. PubMed. 5. 38–38. 36 indexed citations

19.

Saperstein, David A., et al.. (1997). Exogenous Neisseria meningitidis Endophthalmitis. American Journal of Ophthalmology. 123(1). 135–136. 1 indexed citations

20.

Olsen, Timothy W., Thomas M. Aaberg, Paul W. Sternberg, et al.. (1996). The use of autologous fibrinogen and bovine thrombin to close full-thickness macular holes. Investigative Ophthalmology & Visual Science. 37(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact